22 January 2022: Clinical Research
A Questionnaire-Based Study to Obtain a Consensus from 5 Polish Burns Centers on Eschar Removal by Bromelain-Based Enzymatic Debridement (Nexobrid) in Burns Following the 2020 Updated European Consensus Guidelines
Tomasz Korzeniowski 12ABCDEFG* , Jerzy Strużyna 13ACDEFG , Anna M. Chrapusta 4ABCDE , Andrzej Krajewski 5ABDE , Marek Kucharzewski 6ABDEF , Krzysztof Piorun 5ABCE , Jakub Nowakowski 7BCDF , Agnieszka Surowiecka 1ACDE , Magdalena Kozicka 12ABDF , Kamil Torres 12BDEGDOI: 10.12659/MSM.935632
Med Sci Monit 2022; 28:e935632
Table 5 Consensus statements and agreement on early and long-term outcomes after enzymatic debridement.
| s | Statement | Agreement | Likert scale | Consensus |
|---|---|---|---|---|
| 22 | Given its selective effect, enzymatic debridement allows preservation of live dermis more effectively than standard procedures | 100% | 4/5 strongly agree1/5 agree | Yes |
| 23 | Extended conservative treatment after enzymatic debridement may impair the healing process and result in a poorer outcome (hypertrophied scars), which is why additional debridement procedures and skin grafting need to be considered on a regular basis | 100% | 4/5 strongly agree1/5 agree | Yes |
| 24 | Scar treatment after enzymatic debridement needs to follow standard burn care protocols | 100% | 5/5 strongly agree | Yes |